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Sarrhythmias.3,6 Future experiments will focus on using
voltage- or calcium-sensitive dyes to further assess the con-
nectivity of the tissues using optical mapping as described
previously.14
Furthermore, the investigation of the contractile proper-
ties of SMBs embedded in the ETCs and their ability to cou-
ple mechanically to the host myocardium are of significant
importance. In vitro determination of developed force as fa-
tigue testing would provide further insight. In addition to
the in vivo electrical integration of the tissue constructs
that we confirmed previously,14 the functional in vivo inte-
gration of the tissue constructs needs to be investigated and
will be the subject of future projects.
CONCLUSIONS
We demonstrated electrophysiologic coupling of skeletal
myoblast–derived cells with cardiomyocytes in the context
of engineered tissues. This is a decisive step forward toward
the future application of autologous and functionally
competent cells as therapeutic agents for cardiac cell
therapy.
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Dr Y. Joseph Woo (Philadelphia, Pa). Dr Choi, I congratulate
you and your colleagues on an outstanding body of work. Your
work is very innovative. The mechanical preconditioning, your
in vitro transplant model of heart slices, sophisticateddiovascular Surgery c Volume 144, Number 5 1183
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Selectrophysiologic studies, proper biologic controls, and loss of
function and restoration of function controls all should be com-
mended. I have 2 quick questions.
Have you looked at any complementary studies of gap junction
function and electrophysiologic coupling, such as direct imaging
of calcium transients?
Dr Choi. We did not do that. We performed a dye transfer
experiment by immersing one end into calcium AM, the dye was
transferred, and the dye transfer could be stopped by additional ad-
ministration of 1-heptanol.
DrWoo.Would you comment on any ongoing in vivo studies or
speculate on your work transitioning into an in vivo model? Would1184 The Journal of Thoracic and Cardiovascular Surmultiple factors, such as the varied vectors of natural cardiac con-
tractility, potentially decondition your preconditioned myotubules
andmight your engineered construct serve as a focus for a reentrant
tachycardia?
Dr Choi. We also performed transplantation in vivo in mice,
and by small animal magnetic resonance imaging in these mice,
we observed that the size of the scar decreased and the contractility
of the left ventricle increased.
In regard to the other question, we are starting a clinical trial.
We are trying to translate everything to meet the Good
Manufacturing Practice guidelines, and we are just waiting for
approval.gery c November 2012
